CSIMarket
 
Haemonetics Corporation  (NYSE: HAE)
 
Price: $102.9200 $0.07 0.068%
Day's High: $103.56500244140625 Week Perf: -0.15 %
Day's Low: $ 101.51 30 Day Perf: 21.05 %
Volume (M): 423,177 52 Wk High: $ 109.57
Volume (M$): $ 0 52 Wk Avg: $68.86
Open: $101.59 52 Wk Low: $47.32



 Market Capitalization (Millions $) 4,704
 Shares Outstanding (Millions) 46
 Employees 3,023
 Revenues (TTM) (Millions $) 1,352
 Net Income (TTM) (Millions $) 96
 Cash Flow (TTM) (Millions $) -47
 Capital Exp. (TTM) (Millions $) 37

Business Description


Haemonetics Corporation is a U.S. based company that specializes in providing innovative blood management solutions to healthcare facilities and blood donation centers across the globe. The company was founded in 1971 and is headquartered in Braintree, Massachusetts. Haemonetics Corporation has a market cap of roughly $4.4 billion and trades on the New York Stock Exchange under the ticker symbol HAE.

The company has a wide range of products and services including blood collection and processing equipment, blood component extraction and storage systems, and software platforms for blood management. Haemonetics Corporation's major products include:

1. Blood Collection Devices and Systems - Haemonetics Corporation produces a variety of different products designed to collect blood safely and efficiently. These devices include manual and automated collection instruments, needles and tubing, and blood bags.

2. Blood Component Separation and Storage Systems - The company produces systems that separate blood into its various components such as red blood cells, plasma, and platelets. These components can then be stored separately and used for various medical procedures as needed.

3. Blood Management Software - In order to assist healthcare facilities with managing their blood inventory and ensuring patient safety, Haemonetics Corporation offers a range of software applications. These applications allow healthcare professionals to track blood usage, monitor inventory levels, and analyze patient transfusion trends.

Haemonetics Corporation serves a diverse range of clients, including hospitals, blood banks, and surgery centers. The company's products and services are used in a variety of medical procedures, including surgeries, transfusions, and emergency care.

The company has a global presence, with operations in over 50 countries. Haemonetics Corporation employs approximately 3,200 people worldwide and has manufacturing facilities in the U.S., Mexico, and Switzerland.

In recent years, Haemonetics Corporation has made significant investments in research and development, with a focus on developing new products that enhance blood management practices and improve patient outcomes. The company has also been actively acquiring other firms in the industry, further expanding its product portfolio and market share.

Overall, Haemonetics Corporation is a highly reputable and innovative company that is dedicated to providing the highest quality blood management solutions to healthcare facilities worldwide.


   Company Address: 125 Summer Street, Boston, 2110 MA
   Company Phone Number: 848-7100   Stock Exchange / Ticker: NYSE HAE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BIO   -0.41%    
TMO   -1.35%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 50.20
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 3.48
Price to Sales (Expected) -
Price to Book 5.62
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.85
Working Capital Ratio 3.08
Leverage Ratio (MRQ) 1.83
Total Debt to Equity 1.43
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.23

Per Share Current
Earnings (TTM) 2.05 $
Revenues (TTM) 29.58 $
Cash Flow (TTM) -
Cash 4.89 $
Book Value 18.32 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 447,146
Net Income per Employee (TTM) 31,851
Receivable Turnover Ratio (TTM) 6.42
Inventory Turnover Ratio (TTM) 1.68
Asset Turnover Ratio (TTM) 0.54

Profitability Ratios Current
Gross Margin (MRQ) 59.76 %
Operating Margin (MRQ) 16.93 %
Net Margin (MRQ) 9.73 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 26.18 %

Management Effectiveness Current
Return On Assets (TTM) 3.84 %
Return On Investment (TTM) 5.05 %
Return On Equity (TTM) 11.66 %
Dividend Yield -
Pay out Ratio (TTM) -



Haemonetics's Segments
Apheresis    56.37 % of total Revenue
MedSurg    43.63 % of total Revenue
United States    75.98 % of total Revenue
Japan    3.79 % of total Revenue
Europe    13.42 % of total Revenue
Asia    5.94 % of total Revenue
Other Country or Region    0.88 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.